Skinvisible, Inc. financial data

Symbol
SKVI on OTC
Location
6320 S Sandhill Road, Unit 9, Las Vegas, NV
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Apr 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.83 % -53.5%
Debt-to-equity -102 % +0.54%
Return On Equity 12.9 % -63.5%
Return On Assets -363 % +71.4%
Operating Margin -2.95K % -20.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.32M shares +17.1%
Common Stock, Shares, Outstanding 5.32M shares +17.1%
Entity Public Float 3.52M USD +781%
Common Stock, Value, Issued 5.32K USD +17.1%
Weighted Average Number of Shares Outstanding, Basic 5.06M shares +11.5%
Weighted Average Number of Shares Outstanding, Diluted 5.06M shares +11.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 20K USD 0%
Operating Income (Loss) -590K USD -20.2%
Net Income (Loss) Attributable to Parent -566K USD +76.3%
Earnings Per Share, Diluted -0.11 USD/shares +78.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 5K USD 0%
Assets, Current 42K USD +18.5%
Assets 158K USD -2.86%
Liabilities, Current 3.68M USD +4.76%
Liabilities 9.4M USD +2.38%
Retained Earnings (Accumulated Deficit) -39.9M USD -1.44%
Stockholders' Equity Attributable to Parent -9.25M USD -2.47%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -9.25M USD -2.47%
Liabilities and Equity 158K USD -2.86%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.3K USD +76.2%
Net Cash Provided by (Used in) Financing Activities 19.5K USD
Net Cash Provided by (Used in) Investing Activities -525 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 5.32M shares +17.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.21K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.3K USD +1064%
Deferred Tax Assets, Gross 8.4M USD +1.21%
Additional Paid in Capital 30.7M USD +1.09%
Amortization of Intangible Assets 4.7K USD +1.1%
Interest Expense 669K USD -64.5%